Global regulators call for advancing alternatives to animal testing across the medicine lifecycle

EMA has endorsed an ICMRA statement calling on medicine developers, manufacturers, regulators and national control laboratories to advance alternatives to animal testing across the human medicine lifecycle. The statement describes a gradual transition using scientifically valid methods acceptable to regulators.

Why it matters: ICMRA says replacing animal tests requires robust evidence and regulatory acceptance, with countries expected to progress at different speeds.